Diagnostic tests in non-invasively acquired body fluids

Recruiting

Conditions: diagnostische bepalingen
Medical examinations
Diagnostic tests

Registration Number: NL-OMON53111

Lead Sponsor: Academisch Medisch Centrum

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Not specified

Target Recruitment: 100

Inclusion Criteria

Inclusion criteria for healthy volunteers:
18 years or older and mentally competent.
Inclusion criteria for unhealthy volunteers, they must meet one of the
following criteria:
-Having a disease, systemic, metabolic.
-Psyhiatric, somatic, organic or neurological disorder.
-Use of medication which might effect the immune system
-Known to have abnormal blood values

Exclusion Criteria

Healthy volunteers: exclusion criteria:
- Younger than 18 years and mentally incompetent.
-Pregnancy, or presumption of pregnancy
-The use of anticoagulants or having coagulation disorder
-Use of any investigational drug
-Use of somatic medication which may affect the immune system
-Current or recent (<1 year) alcohol or substance abuse
-Current psychiatric disorder or a first degree family member with a major
psychiatric disorder
-Current systemic disease
-Major metabolic disease
-Somatic, organic or neurological disorder, Exclusion criteria unhealthy
volunteers:
- 18 years or younger
- mentally incompetent.

Study & Design

Study Type: Observational invasive

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>- to demonstrate the presence of a compound of interest in blood and sweat,<br /><br>tear fluid, saliva and fingermarks.<br /><br>- to determine the amount/levels of that particular compound in blood and<br /><br>sweat, tear fluid, saliva and fingermarks.<br /><br>- to investigate whether a relation can be found in the levels of a particular<br /><br>compound in blood and sweat, tear fluid, saliva and fingermarks.<br /><br><br /><br>In this study we start with investigating the PSA levels, hormone levels and<br /><br>blood group typing. </p><br>

Secondary Outcome Measures